Tonga vs Western Pacific (WHO region): New cases tested for RR-/MDR-TB
Tonga
100.0%
in 2023
Western Pacific (WHO region)
89.0%
in 2024
Tonga rank
1st
Western Pacific (WHO region) rank
2nd
New cases tested for RR-/MDR-TB over time
- Tonga
- Western Pacific (WHO region)
How they compare
Tonga currently reports 100.0% against 89.0% in Western Pacific (WHO region), a difference of 11.0%.
That makes Tonga's figure about 1.1 times Western Pacific (WHO region)'s.
The two have swapped places 1 time across 14 shared years of data; in 2010 it was Western Pacific (WHO region) ahead.
Tonga ranks 1st and Western Pacific (WHO region) ranks 2nd of 192 countries.
Tonga has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Tonga | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 30.0% | 23.6% | 6.4% | Tonga |
| 2020s | 100.0% | 81.8% | 18.2% | Tonga |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Tonga or Western Pacific (WHO region)?
- Tonga, at 100.0% against 89.0% in Western Pacific (WHO region) as of 2023.
- What is the difference in new cases tested for rr-/mdr-tb between Tonga and Western Pacific (WHO region)?
- 11.0%, with Tonga ahead.
- How many years of comparable data are there for Tonga and Western Pacific (WHO region)?
- 14 years are reported by both, from 2010 to 2023.
- How do Tonga and Western Pacific (WHO region) rank globally for new cases tested for rr-/mdr-tb?
- Tonga ranks 1st and Western Pacific (WHO region) ranks 2nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.